165 related articles for article (PubMed ID: 22127590)
1. Uncommon late relapse of angioimmunoblastic T-cell lymphoma after 16-year remission period.
Páyer E; Miltényi Z; Simon Z; Szabados L; Hegyi K; Méhes G; Illés A
Pathol Oncol Res; 2012 Jul; 18(3):737-41. PubMed ID: 22127590
[No Abstract] [Full Text] [Related]
2. Unusual relapse of an angioimmunoblastic T cell lymphoma 11 years after initial manifestation.
Lohneis P; Jakob C; Hummel M; Jöhrens K; Anagnostopoulos I
Ann Hematol; 2015 Feb; 94(2):347-9. PubMed ID: 24923452
[No Abstract] [Full Text] [Related]
3. Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
Broccoli A; Pellegrini C; Celli M; Argnani L; Agostinelli C; Pileri S; Zinzani PL
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e119-22. PubMed ID: 24629851
[No Abstract] [Full Text] [Related]
4. A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320.
Townsend W; Johnson RJ; Pottinger BT; Counsell N; Smith P; Chadwick H; Evans K; Wickham C; Rudin CE;
Leuk Lymphoma; 2016 Sep; 57(9):2232-4. PubMed ID: 27001186
[No Abstract] [Full Text] [Related]
5. Primary cerebral angioimmunoblastic T-cell lymphoma.
Lachenal F; Berger F; Cimarelli S; Formaglio M; Ghesquières H
J Clin Oncol; 2013 Feb; 31(5):e64-8. PubMed ID: 23295811
[No Abstract] [Full Text] [Related]
6. Therapy refractory angioimmunoblastic T-cell lymphoma in complete remission with lenalidomide.
Beckers MM; Huls G
Eur J Haematol; 2013 Feb; 90(2):162-3. PubMed ID: 23227803
[TBL] [Abstract][Full Text] [Related]
7. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.
Lunning MA; Vose JM
Blood; 2017 Mar; 129(9):1095-1102. PubMed ID: 28115369
[TBL] [Abstract][Full Text] [Related]
8. Secondary Cutaneous Epstein-Barr Virus-associated Diffuse Large B-cell Lymphoma with Hodgkin/Reed-Sternberg-like Cells in a Patient with Angioimmunoblastic T-cell Lymphoma.
Chen H; Xue YN; Xin CM; Xiong JS; Ni X; Sun JF
Acta Derm Venereol; 2018 Nov; 98(10):981-982. PubMed ID: 29956714
[No Abstract] [Full Text] [Related]
9. Neuropathy associated with angioimmunoblastic lymphadenopathy-like T-cell lymphoma.
Sonobe M; Yasuda H; Okabe H; Terada M; Maeda K; Kawabata T; Kikkawa R
Intern Med; 1998 Jul; 37(7):631-4. PubMed ID: 9711895
[TBL] [Abstract][Full Text] [Related]
10. Angioimmunoblastic T-cell lymphoma: new insights, but the clinical challenge remains.
Jaffe ES
Ann Oncol; 1995 Sep; 6(7):631-2. PubMed ID: 8664181
[No Abstract] [Full Text] [Related]
11. A four-year spontaneous remission of angioimmunoblastic T-cell lymphoma.
Cornish N; Maybury B; Otton S
Br J Haematol; 2018 Jan; 180(2):176. PubMed ID: 29048103
[No Abstract] [Full Text] [Related]
12. Targeting CD52 as a novel therapeutic strategy in angioimmunoblastic T-cell lymphoma.
Dunleavy K; Wilson WH
Leuk Lymphoma; 2010 Sep; 51(9):1583-4. PubMed ID: 20795788
[No Abstract] [Full Text] [Related]
13. Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.
Delfau-Larue MH; de Leval L; Joly B; Plonquet A; Challine D; Parrens M; Delmer A; Salles G; Morschhauser F; Delarue R; Brice P; Bouabdallah R; Casasnovas O; Tilly H; Gaulard P; Haioun C
Haematologica; 2012 Oct; 97(10):1594-602. PubMed ID: 22371178
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment with fludarabine in two cases of angioimmunoblastic lymphadenopathy with dysproteinemia.
Hast R; Jacobsson B; Petrescu A; Hjalmar V
Leuk Lymphoma; 1999 Aug; 34(5-6):597-601. PubMed ID: 10492085
[TBL] [Abstract][Full Text] [Related]
15. Hypocomplementemia and hematological abnormalities in immunoblastic lymphadenopathy and immunoblastic lymphadenopathy-like T cell lymphoma.
Higuchi T; Mori H; Niikura H; Omine M
Acta Haematol; 1996; 96(2):68-72. PubMed ID: 8701703
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine.
Tsatalas C; Margaritis D; Kaloutsi V; Martinis G; Kotsianidis I; Bourikas G
Acta Haematol; 2001; 105(2):106-8. PubMed ID: 11408715
[No Abstract] [Full Text] [Related]
17. Elevated absolute monocyte count predicts unfavorable outcomes in patients with angioimmunoblastic T-cell lymphoma.
Yang YQ; Liang JH; Wu JZ; Wang L; Qu XY; Cao L; Zhao XL; Huang DP; Fan L; Li JY; Xu W
Leuk Res; 2016 Mar; 42():88-92. PubMed ID: 26764222
[TBL] [Abstract][Full Text] [Related]
18. Angioimmunoblastic T-cell lymphoma with cutaneous involvement.
Mahendran R; Grant JW; Hoggarth CE; Burrows NP
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):589-90. PubMed ID: 11843225
[No Abstract] [Full Text] [Related]
19. Peripheral T-cell lymphoma: clinicopathologic analyses of 25 cases.
Shimizu K; Nagasaka T; Hara K; Ohnishi K; Hirano M; Kunii A
Jpn J Med; 1989; 28(5):569-76. PubMed ID: 2585883
[TBL] [Abstract][Full Text] [Related]
20. Angioimmunoblastic lymphadenopathy: an etiology for gastrointestinal lymphomatous polyposis.
Goenka MK; Vaiphei K; Nagi B; Sriram PV; Joshi K; Kochhar R
Am J Gastroenterol; 1996 Jun; 91(6):1236-8. PubMed ID: 8651178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
